thyssenkrupp nucera AG & Co. KGaA / DE000NCA0001
18.12.2023 - 07:03:34thyssenkrupp nucera Grew Strongly in the 2022/2023 Financial Year
| thyssenkrupp nucera AG & Co. KGaA / Key word(s): Annual Results thyssenkrupp nucera Grew Strongly in the 2022/2023 Financial Year 18.12.2023 / 07:03 CET/CEST The issuer is solely responsible for the content of this announcement. thyssenkrupp nucera Grew Strongly in the 2022/2023 Financial Year Achieving dynamic and profitable growth through successful project execution and further progress in implementing the growth strategy Order intake in the chlor-alkali business is at a record high High increase in sales primarily due to strong growth momentum in the area of water electrolysis (AWE) for the production of green hydrogen Strong profit growth resulted from high sales growth in AWE business, improved project mix and enhanced project execution in both chlor-alkali and AWE business thyssenkrupp nucera anticipates high sales growth for the 2023/2024 financial year with a significant decline in earnings due to substantial start-up costs associated with the AWE business Dortmund, December 18, 2023 – thyssenkrupp nucera grew strongly in the 2022/2023 financial year (reporting date September 30) with a significant increase in sales and more than two-and-a-half-fold increase in profit. The provider of world-leading technologies for highly efficient electrolysis plants acquired several major projects in the past financial year 2022/2023. This includes the order for the planning and construction of a water electrolysis plant with an installed capacity of more than 700 megawatts (MW). The Swedish company H2 Green Steel will utilize it in their first large-scale green steel plant in Europe to date in northern Sweden. The order, amounting to a low double-digit EUR million, is included in the current reporting year. The majority of the order will be recognized in the new 2023/2024 financial year. At EUR 205.6 million, incoming orders in the alkaline water electrolysis (AWE) segment for producing green hydrogen were, as expected, significantly below the previous year’s figure (EUR 970.1 million), which had reached a record level in the 2021/2022 reporting year due to the major order for the NEOM plant with an output of more than 2 gigawatts in Saudi Arabia. The highly efficient BM2.7 technology from thyssenkrupp nucera, with its sustainable and efficient membrane technology for chlor-alkali (CA) plants, is in great demand for the technical conversion of many existing mercury and diaphragm plants. In the field of CA electrolysis, thyssenkrupp nucera acquired major orders, particularly in the US and Brazil. CA order intake reached a new record level of EUR 407.8 million (previous year: EUR 369.5 million). In total, the electrolysis specialist recorded new orders worth EUR 613.4 million in the 2022/2023 financial year after the record figure of EUR 1,339.6 million in the previous year. Due to the progress made in project execution, the order backlog fell from EUR 1,459.1 million to EUR 1,378.9 million. The company, which is one of the world's leading providers of electrolysis technology, achieved a 70% increase in sales to EUR 652.8 million (previous year: EUR 383.1 million). Here too, the main driver of the increase in sales was the business with AWE systems for producing green hydrogen. AWE sales increased more than six-fold from EUR 50.7 million to EUR 323.2 million in the 2022/2023 reporting year. Sales in the CA segment remained stable, reaching EUR 329.6 million after EUR 332.4 million in the same period of the previous year. While sales in new plant construction increased by 12% to EUR 110.2 million (previous year: EUR 98.6 million), sales in the service business were slightly below the previous year's high figure (EUR 233.8 million) at EUR 219.4 million. In the fourth quarter of 2022/2023, total sales rose by 47% compared to the same period of the previous year to EUR 159.4 million. This growth mainly reflects the significant advancements achieved in the execution of the hydrogen projects in the Netherlands (Shell) and Saudi Arabia (NEOM). In the AWE segment, thyssenkrupp nucera achieved sales of EUR 83.6 million, compared with EUR 25.3 million in the same period of the previous year. In the chlor-alkali business, sales of EUR 75.8 million were achieved after EUR 82.8 million. In the previous fiscal year 2022/2023, the electrolysis specialist spent significantly more on the rapid implementation of its growth strategy. For example, the company focused on developing the necessary organizational capacities to implement its growth strategy. Additionally, the necessary measures were implemented to make thyssenkrupp nucera independent. This included setting up independent administrative structures in preparation for the IPO in July 2023. As part of the growth strategy, the efficiency of the 20 MW AWE module scalum® was also further optimized. This led to a 21% increase in research and development expenses to EUR 19.4 million (previous year: EUR 16.0 million). The increase in the workforce associated with the growing demand for thyssenkrupp nucera's highly efficient electrolysis solutions led to an increase in the number of employees worldwide by almost a third to 675 (previous year: 509). In particular, the more than sixfold increase in AWE sales, an improved project mix and the further optimization of project execution in both the CA and AWE areas enabled EBIT to significantly increase despite significantly higher expenses. This was reinforced by lower expenses for the spin-off of thyssenkrupp nucera in preparation for the IPO than in the previous year. The operating result (earnings before interest and taxes, EBIT) amounted to EUR 23.8 million (previous year: EUR 8.8 million). thyssenkrupp nucera improved its EBIT margin from 2.3% to 3.6%. In the final quarter of 2022/2023, thyssenkrupp nucera achieved an operating result of EUR 3.5 million thanks to the strong operating performance and one-off effects, compared to a loss of EUR 2.6 million in the fourth quarter of the previous year 2021/2022. Due to the increase in interest income, the financial result of EUR 10.6 million was significantly higher than the previous year's figure (EUR 1.8 million). thyssenkrupp nucera more than tripled its net income after taxes to EUR 22.5 million (previous year: EUR 6.0 million). Earnings per share for the 2022/2023 financial year are calculated at EUR 0.21 after EUR 0.06 in the previous year. No dividend payment is planned for the 2022/23 financial year. thyssenkrupp nucera intends to retain future profits to finance further growth in line with its own dividend policy. "In fiscal year 2022/2023, we further expanded our position as a leading global supplier of water electrolysis technology for the production of green hydrogen," says Dr. Werner Ponikwar, CEO of thyssenkrupp nucera. "Sales and profits have developed very positively and offer us a good starting position for the growth program and the further development of the company. We will continue to drive our business forward and take and systematically implement the necessary operational and strategic measures." In the 2022/2023 financial year, free cash flow from continuing operations amounted to EUR 229.1 million (previous year: EUR 23.8 million). The significant increase is due to the termination of participation in the thyssenkrupp Group's cash pool in June 2023. The cash pool balance of EUR 264 million existing at that time was paid out to thyssenkrupp nucera accordingly. Participation in the thyssenkrupp Group's cash pool ended in June 2023. thyssenkrupp nucera significantly increased its net financial assets as a result of the successful IPO on July 7, 2023. As at September 30, 2023, the electrolysis specialist had a net financial balance of EUR 761.3 million (previous year: EUR 274.8 million). The available liquidity of thyssenkrupp nucera amounted to EUR 767.0 million as of September 30, 2023 (previous year: EUR 27.3 million). "Our IPO has further strengthened our good financial position. thyssenkrupp nucera is very well positioned financially to consistently seize entrepreneurial opportunities, especially in the global growth market for green hydrogen, and thus further expand our market position," says Dr. Arno Pfannschmidt, CFO of thyssenkrupp nucera. thyssenkrupp nucera expects significant sales growth in the mid-double-digit percentage range for the new fiscal year 2023/2024 compared to the past fiscal year 2022/2023. The expected growth momentum is mainly driven by the execution of previously contractually agreed projects in the AWE area. Due to the necessary start-up costs for the implementation of the growth strategy and the scaling of the AWE business for the long-term and sustainable improvement of competitiveness and profitability, a negative EBIT figure in the mid-double-digit EUR million range is expected. Photos For inquiries regarding photos, please send an email for further details and assistance.
18.12.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Language: | English |
| Company: | thyssenkrupp nucera AG & Co. KGaA |
| Voßkuhle 38 | |
| 44141 Dortmund | |
| Germany | |
| Phone: | +49 231-22972-7100 |
| E-mail: | info@thyssenkrupp-nucera.com |
| Internet: | www.thyssenkrupp-nucera.com |
| ISIN: | DE000NCA0001 |
| WKN: | NCA000 |
| Indices: | SDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1798431 |
| End of News | EQS News Service |
| |
